Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from academia to industry, the evolution of molecular marker testing, and the potential for EQRx to break the impasse of escalating cancer drug costs.
Dr. Vince Miller, on the Weighty Decision of a Move to Industry, the Barriers to Molecular Marker Testing, and Disrupting the Pricing of Cancer Therapies | BTJ-018
